Results 81 to 90 of about 9,325 (168)

HIPEC application potential in the treatment of extensive carcinomatosis in ovarian cancer (retrospective study)

open access: yesActa Biomedica Scientifica
Background. The high prevalence of advanced forms of cancer currently requires new treatment approaches. Only modern high-tech surgical procedures can provide means for improving the results of treatment.The aim.
S. I. Radostev   +5 more
doaj   +1 more source

Anesthesia and chemotherapy meet: the nursing of the cancer patient undergoing HIPEC in the story of a clinical case

open access: yes
reservedINTRODUZIONE: Dalla storia di vita di un paziente che ho avuto modo di assistere in questo ultimo anno, nasce in me la volontà di approfondire il legame tra anestesia e chemioterapia che è perfettamente incarnato in quella che è l’HIPEC e l ...
SCIVOLETTO, SARA
core  

Paclitaxel as HIPEC-Drug after Surgical Cytoreduction for Ovarian Peritoneal Metastases: A Randomized Phase III Clinical Trial (HIPECOVA)

open access: yesCurrent Oncology
Multidisciplinary strategies have transformed the management of advanced ovarian cancer. We aimed to evaluate the effectiveness of paclitaxel in hyperthermic intraperitoneal chemotherapy (HIPEC) following surgical cytoreduction for ovarian peritoneal ...
Pedro Villarejo Campos   +8 more
doaj   +1 more source

Short-term outcome in patients treated with cytoreduction and HIPEC compared to conventional colon cancer surgery

open access: yes, 2016
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is an extensive procedure with considerable morbidity. Since only few hospitals perform CRS?+?HIPEC, this might lead to confounded outcomes between hospitals when audited ...
Lemmens, Valery E.   +14 more
core   +2 more sources

Future Prospects and Challenges of Hyperthermic Intraperitoneal Chemotherapy in Indonesia

open access: yesIndonesian Journal of Cancer
Background: Peritoneal carcinomatosis (PC) is a condition characterized by the spread of cancer to the peritoneum, often indicating advanced disease and poor prognosis.
Muhamad Airel Pratama   +2 more
doaj   +1 more source

Short-term Quality of Life After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

open access: yesİstanbul Medical Journal, 2018
Introduction: Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have been increasingly performed in many advanced centers of our country.
Özgül Düzgün   +2 more
doaj   +1 more source

Hyperthermic intraperitoneal chemotherapy in patients with incomplete cytoreduction for appendiceal pseudomyxoma peritonei: a 10-year treatment experience in China

open access: yesOrphanet Journal of Rare Diseases
Background To explore the application value of hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with incomplete cytoreduction for appendiceal pseudomyxoma peritonei (PMP). Methods We retrospectively analyzed the clinical data of 526 patients
Bing Wang   +5 more
doaj   +1 more source

Propensity score-matched evaluation of prophylactic hyperthermic intraperitoneal chemotherapy in geriatric patients with locally advanced colorectal cancer: safety and survival benefits

open access: yesBMC Cancer
Aim The role of prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) in elderly patients with locally advanced colorectal cancer (LACRC) remains controversial. This study aimed to evaluate the perioperative safety and survival benefits of HIPEC
Min Yang   +4 more
doaj   +1 more source

Efficacy and safety of laparoscopic pancreaticoduodenectomy combined with a modified perioperative intraperitoneal chemotherapy regimen in resectable pancreatic head cancer: a dual-center retrospective cohort study

open access: yesFrontiers in Oncology
BackgroundSurgical resection for pancreatic cancer is associated with high rates of locoregional recurrence and peritoneal metastasis, leading to poor prognosis. This study aimed to evaluate the safety and efficacy of laparoscopic pancreaticoduodenectomy
Ang Li   +6 more
doaj   +1 more source

Exploring flow rate selection in HIPEC procedures

open access: yes, 2016
Cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) has emerged as a main comprehensive treatment of peritoneal malignancies.
THALES PAULO BATISTA (12720853)   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy